Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital Age.
Sign Up to like & getrecommendations! Published in 2021 at "Trends in pharmacological sciences"
DOI: 10.1016/j.tips.2020.11.014
Abstract: Deregulation of MYC is among the most frequent oncogenic drivers of cancer. Developing targeted therapies against MYC is, therefore, one of the most critical unmet needs of cancer therapy. Unfortunately, MYC has been labelled as… read more here.
Keywords: synthetic lethality; capitalizing synthetic; lethality myc; cancer ... See more keywords